Mark Talamonti to Predictive Value of Tests
This is a "connection" page, showing publications Mark Talamonti has written about Predictive Value of Tests.
Connection Strength
0.142
-
Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume. Cancer. 2007 Sep 15; 110(6):1227-34.
Score: 0.052
-
Preoperative evaluation of pancreatic cystic lesions: cost-benefit analysis and proposed management algorithm. Surgery. 2005 Oct; 138(4):672-9; discussion 679-80.
Score: 0.046
-
Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2014 Dec; 156(6):1504-10; discussion 1510-1.
Score: 0.021
-
Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011 Apr; 253(4):779-85.
Score: 0.017
-
Cystic neoplasms of the pancreas. A clinicopathologic study, including DNA flow cytometry. Arch Surg. 1995 Oct; 130(10):1048-54.
Score: 0.006